ANGIOTECH PHARMACEUTICALS INC Net Cash Provided by (Used in) Operating Activities, Continuing Operations
ANGIOTECH PHARMACEUTICALS INC reported Net Cash Provided by (Used in) Operating Activities, Continuing Operations of $66.43 million for the 12-month period ending 2012-12-31, per its 10-K filed 2013-03-28.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations · last filed 2013-03-28
- ANGIOTECH PHARMACEUTICALS INC net cash provided by (used in) operating activities, continuing operations for the quarter ending 2012-12-31 was $27.55M.
- ANGIOTECH PHARMACEUTICALS INC net cash provided by (used in) operating activities, continuing operations for the quarter ending 2012-09-30 was $3.65M, a 30.64% decline year-over-year.
- ANGIOTECH PHARMACEUTICALS INC net cash provided by (used in) operating activities, continuing operations for the quarter ending 2012-06-30 was $23.36M.
- ANGIOTECH PHARMACEUTICALS INC net cash provided by (used in) operating activities, continuing operations for the quarter ending 2012-03-31 was $11.87M.
- ANGIOTECH PHARMACEUTICALS INC net cash provided by (used in) operating activities, continuing operations for fiscal 2012 was $66.43M.
| Period end | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 2 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 5 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 8 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Operating Activities, Continuing Operations 12 month |
|---|---|---|---|---|---|---|---|
| 2012-12-31 | $27.55M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28 | $31.20M derived: sum of 2 quarters · filed 2013-03-28 | $54.56M derived: sum of 3 quarters · filed 2013-03-28 | $66.43M 10-K · filed 2013-03-28 | |||
| 2012-09-30 | $3.65M 10-Q · filed 2012-11-14 | $27.01M derived: sum of 2 quarters · filed 2012-11-14 | $38.88M 10-Q · filed 2012-11-14 | ||||
| 2012-06-30 | $23.36M 10-Q/A · filed 2012-09-13 | $35.23M 10-Q/A · filed 2012-09-13 | |||||
| 2012-03-31 | $11.87M 10-Q · filed 2012-05-15 | ||||||
| 2011-12-31 | $14.36M 10-K · filed 2013-03-28 | ||||||
| 2011-09-30 | $5.26M 10-Q · filed 2012-11-14 | $3.11M 10-Q · filed 2012-11-14 | |||||
| 2011-06-30 | -$799.00K 10-Q/A · filed 2012-09-13 |